Lv4
500 积分 2022-12-27 加入
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
11小时前
已完结
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity
19天前
已完结
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
2个月前
已完结
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models
3个月前
已完结
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
3个月前
已完结
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes
3个月前
已完结
Hyperactive DCs redirect aged anti-tumor immunity
3个月前
已关闭
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
3个月前
已完结
Tumour burden and efficacy of immune-checkpoint inhibitors
3个月前
已完结
Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study
3个月前
已完结
皖公网安备34019202002308
